Telesis Bio Dividends and Buybacks
Dividend criteria checks 0/6
Telesis Bio does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-2.7%
Buyback Yield
Total Shareholder Yield | -2.7% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
The Market Lifts Telesis Bio, Inc. (NASDAQ:TBIO) Shares 38% But It Can Do More
Apr 17Codex DNA GAAP EPS of -$0.50, revenue of $5.7M; raises FY22 guidance
Aug 09Codex DNA, Inc. (NASDAQ:DNAY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Pfizer's Codex DNA Deal Hints At Lucrative Pivot To mRNA - Keep An Eye On This Space
Jan 06Codex: Synthetic DNA/mRNA Instrument Developer Holds Impressive Upside In 2021
Sep 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if TBIO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if TBIO's dividend payments have been increasing.
Dividend Yield vs Market
Telesis Bio Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (TBIO) | n/a |
Market Bottom 25% (US) | 1.4% |
Market Top 25% (US) | 4.4% |
Industry Average (Life Sciences) | 0.5% |
Analyst forecast (TBIO) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate TBIO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate TBIO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate TBIO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as TBIO has not reported any payouts.